
Blue Star Q2 FY27 Revenue Up 21% to ₹2,422 Cr
Blue Star Limited announced its financial results for the Second Quarter and Half Year ended September 30, 2026. Consolidated Revenue from Operations for Q2 FY27 increased by 21.0% to ₹2,422 crore compared to Q2 FY26. Operating profit (EBITDA) saw a significant improvement of 105% to ₹203 crore, resulting in an operating margin of 6.9%. Profit Before Tax (PBT) stood at ₹134 crore in Q2 FY27, a slight increase from ₹133 crore in Q2 FY26. The company also recorded an exceptional gain of ₹23.02 crore from the slump sale of its MedTech business. The order book grew by 1.5% to ₹7,229 crore as of September 2026, and the company maintained a net cash position of ₹894.3 crore as of September 2026, a substantial improvement from net borrowings of ₹417.06 crore in September 2025.
Key Highlights
- Consolidated Revenue grew 21.0% YoY to ₹2,422 crore in Q2 FY27.
- Operating profit (EBITDA) surged 105% to ₹203 crore.
- Exceptional gain of ₹23.02 crore from MedTech business sale.
- Order book increased 1.5% to ₹7,229 crore.
- Net cash position of ₹894.3 crore, up from net borrowings.
Price Impact
More from BLUESTARCO